Full-Time

Quality Engineer

August Bioservices

August Bioservices

51-200 employees

US-based CDMO for end-to-end drug development

No salary listed

Nashville, TN, USA

In Person

Bachelor's, Master's

Category
Biology & Biotech (1)
Required Skills
Supply Chain Management
Quality Assurance (QA)

Get referred to August Bioservices

See people who can refer or advise you

Requirements
  • A Bachelor's or Master's degree and at least 5 years of experience in Quality Assurance within a biotechnology, biologics, or pharmaceutical manufacturing facility.
  • A proven track record with current good manufacturing practice and technology transfer.
  • Knowledge of good manufacturing practice compliance, including 21 CFR 210, 211, 820, the PICS Guide to Good Manufacturing Practices Parts 1 and 2 or the EU Guidelines to Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use including Annex 1, and Food and Drug Administration Guidance on Aseptic Processing.
  • The ability to efficiently prioritize work and quickly communicate project information to the team in a fast-paced environment.
  • The ability to sit for prolonged periods at a desk and work on a computer.
  • The ability to lift up to 15 pounds at times.
Responsibilities
  • Represent the Quality function in internal and external meetings related to new client projects, determine deliverables and timelines, and communicate upcoming activities with the Quality Organization, including Quality Assurance, Quality Control, and Validation.
  • Support technology transfer of products and processes from clients into August Bioservices manufacturing and laboratories from the Quality perspective across research and development, formulation development, clinical, and commercial manufacturing.
  • Work cross-functionally with internal departments to effectively transfer and maintain processes in the facility.
  • Identify current good manufacturing practice critical-path items, risks, and impediments to successful transfer, and drive the identification and development of solutions to mitigate these risks.
  • Support projects to streamline new product introduction and provide feedback to the Change Review Board for change controls introducing new products.
  • Develop and implement phase-appropriate strategies for efficient transfers and identification of Quality deliverables.
  • Work with Product Quality Assurance and Manufacturing to support generation of appropriate batch documentation.
  • Communicate project status, upcoming deliverables, and timelines to the Quality Organization.
  • Work with Manufacturing, Engineering, Supply Chain, and Commercial Operations to drive technical transfer of client products into August Bioservices for manufacture and laboratory testing.
  • Collaborate with clients and internal cross-functional stakeholders to move projects forward.
  • Provide support during internal audits and regulatory inspections.
  • Adhere to company policies and applicable regulatory agency requirements, including the International Council for Harmonisation and the Food and Drug Administration, to ensure compliance.
  • Communicate with cross-functional teams.
Desired Qualifications
  • Knowledge of 21 CFR Part 11 compliance.

August Bioservices is a US-based CDMO offering end-to-end drug development and manufacturing from pre-clinical to commercial. It combines large-CDMO scale with a customer-focused hybrid model to serve startups and big pharma. It provides full development programs including research, development, testing, lab services, and sterile fill/finish under one integrated process, ensuring cGMP and FDA-quality standards. Its goal is to help clients bring safe, effective drugs to market efficiently through a seamless, integrated pathway.

Company Size

51-200

Company Stage

Series B

Total Funding

$88.6M

Headquarters

Nashville, Tennessee

Founded

2017

Get referred to August Bioservices

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Manufacturing Chemist reported April 2026 plans for lyophilization and fill-finish expansion.
  • August’s 2025 FDA inspection was VAI, with no warning letters on record.
  • March 2026 named Jenn Adams Healthcare Technology CEO of the Year, aiding sales credibility.

What critics are saying

  • August’s 2026 expansion depends on filling new suites before rivals lock customers.
  • Single-site Nashville concentration exposes revenue to one facility outage, inspection, or permitting problem.
  • If sterile-fill demand softens, Oak HC/FT’s capital buildout becomes existentially underutilized.

What makes August Bioservices unique

  • August Bioservices specializes in sterile injectables, not broad-spectrum CDMO services.
  • Its Nashville campus combines development, analytical testing, and fill-finish under one roof.
  • Jenn Adams built August around embedded client teams and end-to-end program ownership.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Relocation Assistance

Employee Referral Bonus

Student Loan Assistance

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Childcare Support

Elder Care Support

Pet Insurance

Bereavement Leave

Professional Development Budget

Conference Attendance Budget

Training Programs

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Wellness Program

Mental Health Support

Gym Membership

Commuter Benefits

Meal Benefits

Phone/Internet Stipend

Home Office Stipend

Legal Services

Employee Discounts

Company Social Events

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-2%
The Healthcare Technology Report
Mar 18th, 2026
Jenn Adams named Healthcare Technology CEO of the Year.

Jenn Adams named Healthcare Technology CEO of the Year. Published. March 18, 2026 At this year's NYC Awards Night, The Healthcare Technology Repo had the privilege of recognizing several exceptional leaders advancing innovation across healthcare technology. Congratulations to Jenn Adams, CEO of August Bioservices, on being named Healthcare Technology CEO of the Year. Jenn has led August Bioservices since its founding in 2020, building a contract development and manufacturing organization (CDMO) dedicated to sterile injectable therapies. Headquartered in Nashville, the company provides development and manufacturing services that help drug developers advance innovative therapies from early development through commercialization. Accepting the award, Jenn shared: "When we started our company five and a half years ago, we had a really clear goal and we set out to build a CDMO focused on sterile injectables that could truly serve as a partner to our clients, providing deep technical expertise and a state-of-the-art facility and equipment - all designed to help advance innovative therapies through development and commercialization. Our aspiration is to show up so fully for our clients that they cannot tell the difference anymore. It's indistinguishable to them who is on their team and who is on our team because we're working shoulder to shoulder to make sure the drug is advanced. And then we're bridging the innovation and bringing it to patients who need that innovation in the form of therapies." Please join The Healthcare Technology Repo in congratulating Jenn Adams on this well-deserved recognition. Picture: Jenn Adams speaks at NYC Awards Night

Teknovation.biz
Dec 13th, 2024
Tennessee Emerges As A Leading State For Bioscience R&D

A new report from the Biotechnology Innovation Organization (BIO) and TEConomy Partners LLC finds Tennessee has emerged as a leading state for bioscience research and development, with bioscience RD accounting... The post Tennessee emerges as a leading state for bioscience RD appeared first on Teknovation.biz.

Teknovation.biz
Jun 30th, 2024
News & Notes | Ut Research Foundation Welcomes Four Interns

Like this story? Please share!News & Notes | UT Research Foundation welcomes four interns ETSU's Innovation Lab Director Dr. Audrey Depelteau served as a judge at last week's 2024 SelectUSA Investment Summit.From Knoxville:To promote the commercialization of University of Tennessee (UT) innovations and to help train the next generation of commercialization professionals, the UT Research Foundation (UTRF) recently welcomed three new interns and one returning intern across its Knoxville and Memphis offices.In Knoxville, Andrea Gutierrez-Cortez and Lauren Williams , rising second-year law students at UT, Knoxville (UTK), joined the team as Commercialization Analysts. Jacob Hale is returning for his second year with UTRF as a Senior Commercialization Analyst. Hale is a rising third-year law student, while Gutierrez-Cortez completed her bachelor’s degree in human biology at the University of California, San Diego, and Williams majored in biomedical engineering at UTK.and , rising second-year law students at UT, Knoxville (UTK), joined the team as Commercialization Analysts. is returning for his second year with UTRF as a Senior Commercialization Analyst. Hale is a rising third-year law student, while Gutierrez-Cortez completed her bachelor’s degree in human biology at the University of California, San Diego, and Williams majored in biomedical engineering at UTK

Teknovation.biz
Oct 22nd, 2023
News & Notes | Expansion Bucks For August Bioservices

Like this story? Please share!. .

Teknovation.biz
Jan 23rd, 2023
Launch Tennessee Provides Ssbci Update, Q4 Tn Deal Flow

Like this story? Please share!. .